Telix Pharmaceuticals Limited Stock
Stocks
TLX
AU000000TLX2
Biotechnology & Medical Research
OTC Markets Traded|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.17 AUD | +2.09% |
|
-5.36% | +35.45% |
| Market Cap | 5.15B 3.59B 3.16B 2.94B 2.7B 5.06B 348B 35.11B 13.69B 170B 13.49B 13.2B 589B | P/E 2026 * |
197x | P/E 2027 * | 93.5x |
|---|---|---|---|---|---|
| Enterprise Value | 5.57B 3.88B 3.41B 3.17B 2.92B 5.47B 376B 37.91B 14.79B 183B 14.57B 14.25B 636B | EV / Sales 2026 * |
3.96x | EV / Sales 2027 * | 3.46x |
| Free-Float |
83.35% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Telix Pharmaceuticals Limited
| 1 day | +2.09% | ||
| 1 week | -5.36% | ||
| Current month | -8.50% | ||
| 1 month | +6.76% | ||
| 3 months | +5.94% | ||
| 6 months | +38.92% | ||
| Current year | +35.45% |
| 1 week | 14.4 |  | 15.73 |
| 1 month | 14.4 | | 17.76 |
| Current year | 8.26 | | 17.76 |
| 1 year | 8.26 | | 21.96 |
| 3 years | 8.2 | | 31.97 |
| 5 years | 3.55 | | 31.97 |
| 10 years | 0.46 | | 31.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 51 | 2017-01-02 | |
Darren Smith
DFI | Director of Finance/CFO | 60 | 2022-07-30 |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 51 | 2017-01-02 | |
Mark Nelson
CHM | Chairman | 66 | 2026-02-02 |
Jann Skinner
BRD | Director/Board Member | 68 | 2018-06-18 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/11/26 | Buy | Director | 10,200 | 0.0030% | ||
| 5/26/26 | Free | Director | 30,048 | 0.0089% | ||
| 5/26/26 | Free | Director | 21,597 | 0.0064% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.09% | -5.36% | -39.61% | +46.43% | 3.53B | |
| +1.08% | -6.74% | -2.31% | +10.45% | 46.06B | |
| +3.13% | +2.34% | +393.21% | +605.08% | 38.91B | |
| +2.14% | +4.98% | +10.55% | +65.45% | 35.57B | |
| +4.43% | +0.25% | +10.64% | -9.17% | 33.13B | |
| +1.23% | -1.99% | -0.05% | +30.76% | 26.42B | |
| +0.29% | -5.92% | - | - | 16.61B | |
| +14.71% | +14.47% | +26.81% | +146.99% | 15.08B | |
| -6.32% | -4.59% | +4.36% | +8.22% | 14.08B | |
| +1.82% | -1.02% | +5.46% | -30.74% | 12.81B | |
| Average | +2.31% | -2.64% | +45.45% | +97.05% | 24.22B | |
| Weighted average by Cap. | +2.22% | -2.54% | +72.33% | +128.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.4B 979M 861M 800M 735M 1.38B 94.78B 9.56B 3.73B 46.23B 3.67B 3.59B 160B | 1.62B 1.13B 996M 925M 851M 1.6B 110B 11.07B 4.32B 53.5B 4.25B 4.16B 186B |
| Net income | 19.8M 13.8M 12.14M 11.28M 10.37M 19.45M 1.34B 135M 52.6M 652M 51.81M 50.69M 2.26B | 41.97M 29.26M 25.73M 23.9M 21.99M 41.23M 2.83B 286M 111M 1.38B 110M 107M 4.79B |
| Net Debt | 412M 287M 253M 235M 216M 405M 27.81B 2.81B 1.09B 13.56B 1.08B 1.05B 47.05B | 460M 321M 282M 262M 241M 452M 31.05B 3.13B 1.22B 15.15B 1.2B 1.18B 52.55B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-23 | A$15.17 | +2.09% | 1,461,693 |
| 26-07-22 | A$14.86 | -2.94% | 1,491,901 |
| 26-07-21 | A$15.31 | +1.39% | 2,441,634 |
| 26-07-20 | A$15.10 | +1.27% | 920,820 |
| 26-07-17 | A$14.91 | -4.48% | 2,136,121 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TLX Stock
Select your edition
All financial news and data tailored to specific country editions
